A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Active, not recruiting · NCT03574571 · Registry updated 2026-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-05-14 | NCT03574571 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
| Memorial Sloan Kettering Cancer Center | 753 |
72 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.